These findings corroborate the idea that BCAP may bias cytokine production toward IFN during inflammation, indicating its potential involvement in IFN-driven diseases like systemic lupus erythematosus (SLE). The gene discussed is IFNA1; the disease is systemic lupus erythematosus.